Back to NewEdge Wealth, LLC NewEdge Wealth, LLC

TCRXTCRX
Showing 8 of 15 quarters

Position history for NewEdge Wealth, LLCNewEdge Wealth, LLC's holdings in TSCAN THERAPEUTICS INC

NewEdge Wealth, LLC holds 91,463 shares of TCRX (TSCAN THERAPEUTICS INC), worth $89,643 as of 2026-Q2. TCRX represents 0.0% of NewEdge Wealth, LLC's portfolio.

Current Value

$89,643

Current Shares

91,463

Total Value Change

-$365,843

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
91,463
0.0%
$89,6430.0%$0.98
0
2026-Q1
Unchanged
91,463
0.0%
$92,3780.0%$1.03
0
2025-Q4
Unchanged
91,463
0.0%
$91,4630.0%$1.03
0
2025-Q3
Unchanged
91,463
0.0%
$103,8110.0%$1.74
0
2025-Q2
Unchanged
91,463
0.0%
$150,9140.0%$1.40
0
2025-Q1
Unchanged
91,463
0.0%
$126,2190.0%$1.35
0
2024-Q4
Unchanged
91,463
0.0%
$278,0480.0%$3.00
0
2024-Q3
Unchanged
91,463
0.0%
$455,4860.0%$5.04
0

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used